Cargando…
Two Cases of Possible Exacerbation of Chronic Rejection After Anti-SARS-CoV-2 Messenger RNA Vaccination: A Case Report
In post–liver transplant recipients, SARS-CoV-2 infection is a health threat, and novel messenger RNA vaccines such as Pfizer BioNTech BNT162b2 and Moderna mRNA-1273 are aggressively recommended. However, there are few reports on their adverse effects, some of which may be potentially fatal. We have...
Autores principales: | Okamoto, Tatsuya, Okajima, Hideaki, Ogawa, Eri, Uebayashi, Elena Yukie, Yamamoto, Miki, Kadohisa, Masashi, Yamada, Yosuke, Minamiguchi, Sachiko, Haga, Hironori, Hatano, Etsurou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708617/ https://www.ncbi.nlm.nih.gov/pubmed/36572611 http://dx.doi.org/10.1016/j.transproceed.2022.11.009 |
Ejemplares similares
-
The New Challenge in Pediatric Liver Transplantation: Chronic Antibody-Mediated Rejection
por: Uebayashi, Elena Yukie, et al.
Publicado: (2022) -
Management of Epstein–Barr Virus Infection and Post-Transplant Lymphoproliferative Disorder in Pediatric Liver Transplantation
por: Okamoto, Tatsuya, et al.
Publicado: (2022) -
Effects of Adding Congested Segment IV to the Left Lateral Graft on Short-term Outcomes in Pediatric Living-donor Liver-transplant Recipients
por: Aoki, Hikaru, et al.
Publicado: (2023) -
The impact of human leukocyte antigen mismatch on recipient outcomes in living‐donor liver transplantation
por: Tajima, Tetsuya, et al.
Publicado: (2022) -
Central nervous system mature teratoma producing carbohydrate antigen 19-9: illustrative case
por: Takeuchi, Shu, et al.
Publicado: (2022)